PP
KRRO icon

PDT Partners’s Korro Bio KRRO Stock Holding History

PDT Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-468
Closed -$50K – 1063
2022
Q1 		$50K Sell
468
-431
-48% -$82.3K ﹤0.01% 905
2021
Q4 		$231K Sell
899
-782
-47% -$238K 0.02% 738
2021
Q3 		$593K Sell
1,681
-1,841
-52% -$725K 0.04% 435
2021
Q2 		$1.75M Buy
3,522
+2,627
+294% +$1.28M 0.12% 288
2021
Q1 		$425K Buy
+895
New +$1.74M 0.03% 536

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's KRRO Position: Q2 2022 in Review

PDT Partners sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 468 shares — an estimated $50K sold.

PDT Partners first reported a position in KRRO in Q1 2021 and held it in 5 quarters. The position peaked at $1.75M in Q2 2021. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

  • PDT Partners reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 468 Korro Bio shares in Q2 2022, an estimated $50K.
  • PDT Partners first reported a position in Korro Bio in Q1 2021 and held it in 5 quarters.
  • PDT Partners's Korro Bio position peaked at $1.75M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.